Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Michael A. Ueberall & Gerhard Mueller-Schwefe. (2022) COMET – effectiveness and tolerability of methocarbamol versus oral opioid-analgesics as add-on measure in patients with non-specific low back pain refractory to recommended 1st line treatments. A retrospective analysis of depersonalized propensity score matched open-label real-world 4-week data from the German Pain e-Registry. Current Medical Research and Opinion 38:2, pages 237-253.
Read now
Read now
Michael A. Ueberall, Ute Essner, Gerhard Müller-Schwefe, Johannes Horlemann & Martin Storr. (2022) Prevalence of drug-induced constipation and severity of associated biopsychosocial effects in patients with nonmalignant pain: a cross-sectional review of depersonalized data from the German Pain e-Registry. Current Medical Research and Opinion 38:1, pages 101-114.
Read now
Read now
Shankar Ganesh & Mritunjay Kumar. (2021) Physiotherapist management of a patient with spastic perineal syndrome and subsequent constipation: a case report. Physiotherapy Theory and Practice 37:1, pages 242-251.
Read now
Read now
Alvin Ibarra, Mathilde Latreille-Barbier, Yves Donazzolo, Xavier Pelletier & Arthur C. Ouwehand. (2018) Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes 9:3, pages 236-251.
Read now
Read now
Gineke Koopmans-Klein, Joeri Van Op den Bosch, Yvonne van Megen, Hans Prenen, Frank Huygen & Isabelle Mancini. (2017) Prolonged release oxycodone and naloxone treatment counteracts opioid-induced constipation in patients with severe pain compared to previous analgesic treatment. Current Medical Research and Opinion 33:12, pages 2217-2227.
Read now
Read now
María Dueñas, Liliane Mendonça, Rute Sampaio, Cláudia Gouvinhas, Daniela Oliveira, José Manuel Castro-Lopes & Luís Filipe Azevedo. (2017) Reliability and validity of the Bowel Function Index for evaluating opioid-induced constipation: translation, cultural adaptation and validation of the Portuguese version (BFI-P). Current Medical Research and Opinion 33:3, pages 563-572.
Read now
Read now
Amir Rumman, Zane R. Gallinger & Louis W. C. Liu. (2016) Opioid induced constipation in cancer patients: pathophysiology, diagnosis and treatment. Expert Review of Quality of Life in Cancer Care 1:1, pages 25-35.
Read now
Read now
Marzia Lazzari, Maria Teresa Greco, Claudio Marcassa, Simona Finocchi, Clarissa Caldarulo & Oscar Corli. (2015) Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis. Drug Design, Development and Therapy 9, pages 5863-5872.
Read now
Read now
Guido Fanelli & Andrea Fanelli. (2015) Developments in managing severe chronic pain: role of oxycodone–naloxone extended release. Drug Design, Development and Therapy 9, pages 3811-3816.
Read now
Read now
Wojciech Leppert. (2015) Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction. Drug Design, Development and Therapy 9, pages 2215-2231.
Read now
Read now
Fabio Guerriero, Carmelo Sgarlata, Claudio Marcassa, Giovanni Ricevuti & Marco Rollone. (2015) Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients. Clinical Interventions in Aging 10, pages 1-11.
Read now
Read now
Sabine Hesselbarth, Kai Hermanns & Petra Oepen. (2015) Prolonged-release oxycodone/naloxone in opioid-naïve patients – subgroup analysis of a prospective observational study. Expert Opinion on Pharmacotherapy 16:4, pages 457-464.
Read now
Read now
Thomas Nolte, Ulf Schutter & Oliver Loewenstein. (2014) Cancer pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: results from a non-interventional study. Pragmatic and Observational Research 5, pages 1-13.
Read now
Read now
M. Lazzari, A. F. Sabato, C. Caldarulo, M. Casali, P. Gafforio, C. Marcassa & F. Leonardis. (2014) Effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain: an observational analysis. Current Medical Research and Opinion 30:4, pages 555-564.
Read now
Read now
L. Abramowitz, N. Béziaud, C. Caussé, B. Chuberre, F. A. Allaert & S. Perrot. (2013) Further validation of the psychometric properties of the Bowel Function Index for evaluating opioid-induced constipation (OIC). Journal of Medical Economics 16:12, pages 1434-1441.
Read now
Read now
L. Abramowitz, N. Béziaud, L. Labreze, V. Giardina, C. Caussé, B. Chuberre, F. A. Allaert & S. Perrot. (2013) Prevalence and impact of constipation and bowel dysfunction induced by strong opioids: a cross-sectional survey of 520 patients with cancer pain: DYONISOS study. Journal of Medical Economics 16:12, pages 1423-1433.
Read now
Read now
Philippe Ducrotté & Christian Caussé. (2012) The Bowel Function Index: a new validated scale for assessing opioid-induced constipation. Current Medical Research and Opinion 28:3, pages 457-466.
Read now
Read now
Kai Hermanns, Uwe Junker & Thomas Nolte. (2012) Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain – results from a large observational study. Expert Opinion on Pharmacotherapy 13:3, pages 299-311.
Read now
Read now
Benoît Coffin & Christian Caussé. (2011) Constipation assessment scales in adults: a literature review including the new Bowel Function Index. Expert Review of Gastroenterology & Hepatology 5:5, pages 601-613.
Read now
Read now
Articles from other publishers (28)
K.R.J. Kistemaker, A. de Graeff, M. Crul, G. de Klerk, P.M. van de Ven, M.P. van der Meulen, L. van Zuylen & M.A.H. Steegers. (2023) Magnesium hydroxide versus macrogol/electrolytes in the prevention of opioid-induced constipation in incurable cancer patients: study protocol for an open-label, randomized controlled trial (the OMAMA study). BMC Palliative Care 22:1.
Crossref
Crossref
Michael A. Überall, Heinrich Binsfeld, Michael Küster, Silvia Maurer, Norbert Schürmann & Johannes Horlemann. (2022) Medikamenteninduzierte Verstopfung bei Patienten mit nicht tumorbedingten Schmerzen. Schmerzmedizin 38:5, pages 23-41.
Crossref
Crossref
Akihiro Tokoro, Hisao Imai, Soichi Fumita, Toshiyuki Harada, Toshio Noriyuki, Makio Gamoh, Masaharu Okamoto, Yusaku Akashi & Yoshiyuki Kizawa. (2021) Opioid-Induced Constipation in Patients with Cancer Pain in Japan (OIC-J Study): A Post Hoc Analysis. Journal of Clinical Medicine 10:18, pages 4193.
Crossref
Crossref
Demis N. Lipe. 2021. Oncologic Emergency Medicine. Oncologic Emergency Medicine
367
375
.
Toshiki Mimura. 2021. Pelvic Floor Disorders. Pelvic Floor Disorders
741
752
.
Kordula Lang-Illievich & Helmar Bornemann-Cimenti. (2019) Opioid-induced constipation: a narrative review of therapeutic options in clinical management. The Korean Journal of Pain 32:2, pages 69-78.
Crossref
Crossref
Alvin Ibarra, Tetyana Pelipyagina, Matthew Rueffer, Malkanthi Evans & Arthur Ouwehand. (2019) Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial. Nutrients 11:2, pages 439.
Crossref
Crossref
Brian Hanson, Shazia Mehmood Siddique, Yolanda Scarlett & Shahnaz Sultan. (2019) American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation. Gastroenterology 156:1, pages 229-253.e5.
Crossref
Crossref
Bart J. Morlion, Stefan A. Mueller‐Lissner, Renato Vellucci, Wojciech Leppert, Benoît C. Coffin, Sara L. Dickerson & Tony O'Brien. (2017) Oral Prolonged‐Release Oxycodone/Naloxone for Managing Pain and Opioid‐Induced Constipation: A Review of the Evidence. Pain Practice 18:5, pages 647-665.
Crossref
Crossref
Adam D Farmer, Caroline Bruckner Holt, Thomas J Downes, Eugenio Ruggeri, Sara Del Vecchio & Roberto De Giorgio. (2018) Pathophysiology, diagnosis, and management of opioid-induced constipation. The Lancet Gastroenterology & Hepatology 3:3, pages 203-212.
Crossref
Crossref
Emilia Dadura, Piotr Stępień, Dagmara Iwańska & Agnieszka Wójcik. (2017) Effects of abdominal massage on constipation in palliative care patients – a pilot study. Advances in Rehabilitation 31:4, pages 19-34.
Crossref
Crossref
C. Wolfert, M. Merbach, G. Stammler, O. Emrich, A. M. Meid, J. Burhenne, A. Blank & G. Mikus. (2017) Management von chronischem Schmerz mit retardiertem TilidinManagement of chronic pain using extended release tilidine. Der Schmerz 31:5, pages 516-523.
Crossref
Crossref
Anton Emmanuel, Martin Johnson, Paula McSkimming & Sara Dickerson. (2016) Laxatives Do Not Improve Symptoms of Opioid-Induced Constipation: Results of a Patient Survey. Pain Medicine, pages pnw240.
Crossref
Crossref
Asbjørn M. Drewes, Pia Munkholm, Magnus Simrén, Harald Breivik, Ulf E. Kongsgaard, Jan G. Hatlebakk, Lars Agreus, Maria Friedrichsen & Lona L. Christrup. (2016) Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction–Recommendations of the Nordic Working Group. Scandinavian Journal of Pain 11:1, pages 111-122.
Crossref
Crossref
Charles E. Argoff, Michael J. Brennan, Michael Camilleri, Andrew Davies, Jeffrey Fudin, Katherine E. Galluzzi, Jeffrey Gudin, Anthony Lembo, Steven P. Stanos & Lynn R. Webster. (2015) Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation. Pain Medicine 16:12, pages 2324-2337.
Crossref
Crossref
Lynn R. Webster. (2015) Opioid-Induced Constipation. Pain Medicine 16:suppl 1, pages S16-S21.
Crossref
Crossref
Jan Poelaert, Gineke Koopmans-Klein, Alioune Dioh, Frédéric Louis, Mayken Gorissen, David Logé, Joeri Van Op den bosch & Yvonne J.B. van Megen. (2015) Treatment With Prolonged-Release Oxycodone/Naloxone Improves Pain Relief and Opioid-Induced Constipation Compared With Prolonged-Release Oxycodone in Patients With Chronic Severe Pain and Laxative-Refractory Constipation. Clinical Therapeutics 37:4, pages 784-792.
Crossref
Crossref
Bart Morlion, Katri Elina Clemens & Will Dunlop. (2014) Quality of Life and Healthcare Resource in Patients Receiving Opioids for Chronic Pain: A Review of the Place of Oxycodone/Naloxone. Clinical Drug Investigation 35:1, pages 1-11.
Crossref
Crossref
Arturo Cuomo, Gennaro Russo, Gennaro Esposito, Cira Antonietta Forte, Marianna Connola & Claudio Marcassa. (2013) Efficacy and Gastrointestinal Tolerability of Oral Oxycodone/Naloxone Combination for Chronic Pain in Outpatients With Cancer. American Journal of Hospice and Palliative Medicine® 31:8, pages 867-876.
Crossref
Crossref
Sabine Hesselbarth, Oliver Löwenstein & Thomas Cegla. (2014) Effects of prolonged-release oxycodone/naloxone on pain control, bowel function and quality of life: A prospective observational study. Scandinavian Journal of Pain 5:2, pages 75-81.
Crossref
Crossref
Rafael Gálvez, Mariano Provencio, Manuel Cobo, Cristina Pérez, Concha Pérez & Jaume Canal. (2014) Prevalencia y severidad de la disfunción intestinal inducida por opioides. Atención Primaria 46:1, pages 32-39.
Crossref
Crossref
William C. Becker, Liana Fraenkel, Jennifer E. Edelman, Stephen R. Holt, Janis Glover, Robert D. Kerns & David A. Fiellin. (2013) Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: A systematic review. Pain 154:6, pages 905-916.
Crossref
Crossref
Antonio Gatti, Manuela Casali, Marzia Lazzari, Giuseppe Tufaro, Paolo Gafforio, Claudia Silvestri, Claudio Marcassa & Alessandro F. Sabato. (2012) Prolonged-Release Oxycodone/Naloxone in Nonmalignant Pain: Single-Center Study in Patients with Constipation. Advances in Therapy 30:1, pages 41-59.
Crossref
Crossref
Sam H Ahmedzai, Friedemann Nauck, Gil Bar-Sela, Björn Bosse, Petra Leyendecker & Michael Hopp. (2011) A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain. Palliative Medicine 26:1, pages 50-60.
Crossref
Crossref
Giovambattista ZeppetellaG. Zeppetella. 2012. Palliative Care in Clinical Practice. Palliative Care in Clinical Practice
25
152
.
Andreas Sandner-Kiesling. (2011) Re: Opioid-Induced Constipation: Challenges and Therapeutic Opportunities. American Journal of Gastroenterology 106:12, pages 2200.
Crossref
Crossref
Marie-Louise Navez, Florentin Clère, Youlia Kirova, Claire Josse, Bertrand Chuberre & Christian Caussé. (2011) Caractéristiques cliniques des douleurs cancéreuses sévères chez les patients traités par oxycodone. Cohorte OCS2. Douleurs : Evaluation - Diagnostic - Traitement 12:3, pages 110-122.
Crossref
Crossref
MA Ueberall, S Müller-Lissner, C Buschmann-Kramm & B Bosse. (2011) The Bowel Function Index for Evaluating Constipation in Pain Patients: Definition of a Reference Range for a Non-Constipated Population of Pain Patients. Journal of International Medical Research 39:1, pages 41-50.
Crossref
Crossref